ADA and inflammatory bowel disease: Anti-TNFs, ADA and IFX, have been demonstrated to be effective for both indications (IBD and psoriasis) [126,127]; however, it should be noted that, in some patients, anti-TNFs can induce paradoxical psoriasis and make preexistent lesions worse.